Analysed INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) News Sources
Altruist Biologics Congratulates Partner LongBio Pharma on the BLA Acceptance of LP-003 by the China NMPA
14-09-2026
yahoo.com
Altruist Biologics' Suzhou Site Receives EMA GMP Certification, Enabling Product Commercialization for the European Market
22-09-2026
yahoo.com
Innovent to Present New Clinical Data of Next-gen IO and ADC Pipeline at the 2026 ESMO Annual Meeting
23-09-2026
yahoo.com
Innovent Announces Expansion of Global Phase 3 MarsLight-11 Study of IBI363/TAK-928 (Alpha-biased IL-2/PD-1 Bispecific Fusion Protein) in Immunotherapy-Resistant NSCLC to Include Patients with Non-Squamous NSCLC
28-09-2026
yahoo.com
Jaypirca® (pirtobrutinib) Approved in China for a New Indication in Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) Across All Lines of Therapy
28-09-2026
yahoo.com
2026 IMS Oral Presentation: Innovent Announces Updated Phase 1 Clinical Data of Trispecific Antibody IBI3003 (GPRC5D/BCMA/CD3) in Patients with Relapsed or Refractory Multiple Myeloma
29-09-2026
yahoo.com
Innovent Biologics (SEHK:1801) Stock Still Looks Below Fair Value As Shares Rose 153%
29-09-2026
yahoo.com
What is the current price of INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS)?
The current price of INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) is $54.29.
INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) since the previous trading day is $0.
INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) since the previous trading day is 0%.
What is the most recent average sentiment score for INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS)?
The most recent average sentiment score for INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) is 71 out of 100.
What is the most recent average sentiment for INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS)?
The most recent sentiment for INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) is .
SEC-8K** Filing Available For INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.